Client News

Abivax Announces Presentation of Four Abstracts for Obefazimod in Ulcerative Colitis and Preclinical Colon Cancer Model at Digestive Disease Week 2024

Formycon Reports on Successful Operating Business and Financial Figures for the First Quarter of 2024

Abivax Annual Ordinary and Extraordinary General Meeting of May 30, 2024 – Availability of the Preparatory Documents

Syntekabio to Showcase Biologics Discovery Platform at PEGS Boston

Mainz Biomed to Present Results of Colorectal Cancer Screening Study eAArly DETECT at Digestive Disease Week 2024 in Washington, D.C.

Formycon Invites to the Annual General Meeting on June 12, 2024 in Munich

neurocare group AG Appoints Tariq El-Titi as Senior Vice President MENA, Strengthening Commitment to Middle East Health Sector

Rentschler Biopharma Appoints Patrick Cushing as VP Operations for U.S. Subsidiary

Medigene AG Expands Patent Portfolio with European Patent Grant for its NY-ESO-1 – Targeted T Cell Receptor

Medigene Presents Superior TCR-T Cell Functionality by Inclusion of a Costimulatory Switch Protein